Global Veterinary Reference Laboratory Market Size, Share, and COVID-19 Impact Analysis, By Technology (Clinical Chemistry, Immunodiagnostics, Molecular Diagnostics, Hematology, Urinalysis, and Others), By Application (Clinical Pathology, Bacteriology, Virology, Parasitology, Productivity Testing, Pregnancy Testing, and Toxicology Testing), By Animal Type (Companion Animals and Livestock Animals), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2032
Industry: HealthcareGlobal Veterinary Reference Laboratory Market Insights Forecasts to 2032
- The Global Veterinary Reference Laboratory Market Size was valued at USD 3.80 Billion in 2022.
- The Global Veterinary Reference Laboratory Market Size is growing at a CAGR of 10.6% from 2023 to 2032
- The Worldwide Veterinary Reference Laboratory Market Size is expected to reach USD 10.41 Billion by 2032
- Asia-Pacific is expected to grow higher during the forecast period
Get more details on this report -
The Global Veterinary Reference Laboratory Market Size is expected to reach USD 10.41 billion by 2032, at a CAGR of 10.6% during the forecast period 2023 to 2032.
Market Overview
A veterinary reference laboratory is a specialized facility dedicated to diagnosing and monitoring animal health through advanced laboratory testing. These laboratories play a crucial role in veterinary medicine by offering a comprehensive range of diagnostic services to support veterinarians in accurately identifying and treating diseases in animals. They utilize state-of-the-art equipment and employ highly trained experts to perform various tests, including blood chemistry, hematology, microbiology, histopathology, and molecular diagnostics. Veterinary Reference Laboratories cater to a wide range of animal species, from companion animals like dogs and cats to livestock, exotic pets, and wildlife. By providing fast and accurate results, these facilities aid in early disease detection, guiding appropriate treatment plans, and safeguarding animal populations' health, making them indispensable contributors to the field of veterinary medicine.
Report Coverage
This research report categorizes the market for veterinary reference laboratory market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the veterinary reference laboratory market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segments of the veterinary reference laboratory market.
Global Veterinary Reference Laboratory Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2022 |
Market Size in 2022: | USD 3.80 Billion |
Forecast Period: | 2022-2032 |
Forecast Period CAGR 2022-2032 : | 10.6% |
2032 Value Projection: | USD 10.41 Billion |
Historical Data for: | 2018-2021 |
No. of Pages: | 200 |
Tables, Charts & Figures: | 130 |
Segments covered: | By Technology, By Application, By Animal Type, By Region, and COVID-19 Impact Analysis |
Companies covered:: | IDEXX Laboratories, Inc., GD Animal Health, Zoetis Inc., NEOGEN Corporation, LABOKLIN GMBH & CO.KG, Heska Corporation, Virbac, Vaxxinova Gmbh, Thermo Fisher Scientific Inc., Boehringer Ingelheim International GmbH., Colorado State University, Nova Biomedical, Antech Diagnostics, and Inc. And Other Key Venders. |
Pitfalls & Challenges: | COVID-19 has the potential to impact the global market |
Get more details on this report -
Driving Factors
The veterinary reference laboratory market is driven by several key factors because the increasing prevalence of animal diseases and the growing awareness among pet owners and veterinarians about the benefits of early diagnosis and precise treatment fuel the demand for advanced diagnostic services. Additionally, the rising adoption of companion animals and the subsequent surge in veterinary healthcare expenditure contribute to the market's growth. Furthermore, advancements in technology, such as molecular diagnostics and automation, enhance the efficiency and accuracy of testing procedures, attracting more customers to these laboratories. The expanding trend of pet insurance coverage also plays a significant role as it encourages pet owners to seek comprehensive diagnostic services. Moreover, the integration of telemedicine and online platforms facilitates easy access to laboratory services, further propelling market expansion. Overall, these drivers create a favorable environment for the continuous development and expansion of the veterinary reference laboratory market.
Restraining Factors
The veterinary reference laboratory market faces several restraints that impact its growth prospects. One major restraint is the high cost associated with advanced diagnostic tests and equipment, which can deter some pet owners and veterinarians from seeking these services. Limited awareness and accessibility of reference laboratories, especially in rural or remote areas, also pose challenges. Additionally, regulatory hurdles and compliance requirements for operating such facilities can create barriers to entry and expansion. Moreover, the preference for traditional diagnostic methods in certain regions may hinder the adoption of advanced laboratory services. Economic downturns and fluctuations can further influence the market negatively, leading to reduced spending on veterinary healthcare.
Market Segmentation
- In 2022, the clinical chemistry segment accounted for around 38.5% market share
On the basis of the technology, the global veterinary reference laboratory market is segmented into clinical chemistry, immunodiagnostics, molecular diagnostics, hematology, urinalysis, and others. The clinical chemistry segment has emerged as the dominant force in the veterinary reference laboratory market due to several compelling reasons. Clinical chemistry tests play a crucial role in diagnosing and monitoring various health conditions in animals, making them an essential component of routine veterinary diagnostics. These tests assess biochemical parameters in blood and other bodily fluids, providing valuable insights into an animal's organ function, metabolic processes, and overall health status. The growing prevalence of chronic and lifestyle-related diseases in animals has increased the demand for comprehensive diagnostic evaluations, which is effectively addressed by clinical chemistry tests. Conditions such as diabetes, liver and kidney disorders, and thyroid imbalances are on the rise, necessitating accurate and timely diagnosis for proper disease management. Moreover, the advancements in technology have significantly improved the efficiency and accuracy of clinical chemistry tests. Automation and high-throughput analyzers have streamlined the testing process, allowing laboratories to handle a large volume of samples efficiently. Additionally, these advancements have reduced the turnaround time for test results, enabling veterinarians to make timely treatment decisions. Furthermore, the increasing focus on preventive healthcare in veterinary medicine has driven the demand for wellness screenings and early disease detection. Clinical chemistry tests are an integral part of wellness check-ups, enabling veterinarians to identify potential health issues before they manifest into severe conditions, thus promoting better animal health and longevity.
- In 2022, the clinical pathology segment dominated with more than 34.7% market share
Based on the type of application, the global veterinary reference laboratory market is segmented into clinical pathology, bacteriology, virology, parasitology, productivity testing, pregnancy testing, and toxicology testing. The clinical pathology segment has emerged as the dominant force in the veterinary reference laboratory market, capturing a significant share, for several compelling reasons. Clinical pathology encompasses a wide range of diagnostic tests that evaluate cellular and tissue samples, including hematology, cytology, and histopathology. These tests provide crucial insights into the cellular and molecular aspects of diseases, helping veterinarians diagnose and monitor various health conditions in animals. Hematology tests, which analyze blood samples, are fundamental in assessing an animal's overall health and detecting infections, anemia, and other blood disorders. Cytology involves the examination of individual cells, aiding in the diagnosis of tumors, inflammations, and infections. Histopathology, on the other hand, evaluates tissue samples, offering valuable information about the nature and progression of diseases, particularly in cases of tumors and organ abnormalities. The dominance of the clinical pathology segment can be attributed to its indispensable role in the diagnostic process. Veterinarians heavily rely on these tests to obtain critical information about an animal's health status, guide treatment decisions, and monitor therapeutic progress. Moreover, advancements in laboratory technology and techniques have significantly improved the accuracy and efficiency of clinical pathology tests. Automated hematology analyzers, digital cytology systems, and sophisticated imaging tools have revolutionized the diagnostic process, allowing for faster and more precise results. Furthermore, the increasing prevalence of complex diseases in animals, including cancers and chronic illnesses, has heightened the demand for precise and comprehensive diagnostic evaluations, which clinical pathology tests deliver effectively.
Regional Segment Analysis of the Veterinary Reference Laboratory Market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
North America dominated the market with more than 40.8% revenue share in 2022.
Get more details on this report -
Based on region, North America dominates the veterinary reference laboratory market due to several key factors, the region has a well-established and advanced veterinary healthcare infrastructure, with a high concentration of skilled veterinarians and pet owners who prioritize animal health. North America experiences a significant prevalence of pet ownership, with a considerable population of companion animals, leading to a greater demand for diagnostic services. Additionally, the region is at the forefront of technological advancements in veterinary diagnostics, with a strong presence of leading reference laboratory companies that offer cutting-edge testing capabilities. Moreover, favorable government initiatives and pet insurance coverage contribute to increased utilization of veterinary services. The region's robust economy and higher disposable income levels further support the growth of the veterinary reference laboratory market in North America, solidifying its dominant position in the industry.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the global veterinary reference laboratory market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Companies:
- IDEXX Laboratories, Inc.
- GD Animal Health, Zoetis Inc.
- NEOGEN Corporation
- LABOKLIN GMBH & CO.KG
- Heska Corporation
- Virbac, Vaxxinova Gmbh
- Thermo Fisher Scientific Inc.
- Boehringer Ingelheim International GmbH.
- Colorado State University
- Nova Biomedical
- Antech Diagnostics, Inc.
Key Target Audience
- Market Players
- Investors
- End-Users
- Government Authorities
- Consulting and Research Firm
- Venture Capitalists
- Value-Added Resellers (VARs)
Recent Developments
- In November 2022, VolitionRx Limited has launched its Nu.Q Vet Cancer Screening Test in partnership with Heska Corporations' veterinary diagnostic laboratories in the United States and Europe. By collaborating with Heska, VolitionRx aims to expand the availability of its advanced cancer screening technology to previously underserved regions in the veterinary market. This strategic plan will enable more veterinarians and pet owners to access cutting-edge diagnostic services for early cancer detection in animals, potentially improving treatment outcomes and overall animal health in these regions.
- In June 2022, IDEXX Laboratories Inc. has introduced new reference laboratory tests and services, catering to various aspects of veterinary care. These offerings enable veterinarians to gain valuable insights during wellness screenings, facilitating proactive healthcare measures for animals. Additionally, the company's specialized tests assist in developing effective treatment plans for cats with chronic renal illness, addressing a prevalent condition in feline patients.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2019 to 2032. Spherical Insights has segmented the global veterinary reference laboratory market based on the below-mentioned segments:
Veterinary Reference Laboratory Market, By Technology
- Clinical Chemistry
- Immunodiagnostics
- Molecular Diagnostics
- Hematology
- Urinalysis
- Others
Veterinary Reference Laboratory Market, By Application
- Clinical Pathology
- Bacteriology
- Virology
- Parasitology
- Productivity Testing
- Pregnancy Testing
- Toxicology Testing
Veterinary Reference Laboratory Market, By Animal Type
- Companion Animals
- Livestock Animals
Veterinary Reference Laboratory Market, Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
Need help to buy this report?